NCT07090538 2025-07-29GSL Synthetase Inhibitor Plus GM-CSF and/ or Immune Checkpoint Inhibitor in Previously Treated High-Risk Neuroblastoma.Chinese PLA General HospitalPhase EARLY_PHASE1 Not yet recruiting10 enrolled